Lawsuits Over Testosterone Generic Drugs Survive Pre-emption for Fraudulent Off-Label Marketing
A federal judge has ruled that plaintiffs can continue to pursue off-label marketing claims against generic testosterone drug manufacturers, even though failure to warn claims are preempted.